Ivabradine and metoprolol differentially affect cardiac glucose metabolism despite similar heart rate reduction in a mouse model of dyslipidemia

In a dyslipidemic mouse model, cardiac glucose metabolism and protein O-GlcNAcylation are altered with disease progression before contractile dysfunction. These alterations were attenuated with the...